SoLongevity

SoLongevity has built arguably the most scientifically credible longevity medicine platform in Italy, led by an immunologist Professor as Scientific Director and a sports physician as Medical Director. The flagship Age360 program analyzes over 700 biomarkers to create comprehensive biological age profiles, supplemented by the proprietary BioClock DNA methylation test for tracking epigenetic aging over time. The Milan clinic offers IV therapies, phototherapy, oxygen-ozone treatments, molecular hydrogen inhalation, and hypoxic training. The scientific leadership brings genuine academic depth, and the 700+ biomarker protocol is among the most comprehensive available in Southern Europe. Italian and European press recognition reflects growing awareness of SoLongevity's clinical innovation. The BioClock epigenetic tracking tool provides a valuable longitudinal dimension, allowing patients to measure the impact of interventions over time. The nutraceutical product line (CellFasting, NeuroProtection, CardioAge) has earned strong consumer ratings, and the supplement business adds a commercial dimension alongside the clinical practice. Some patients may prefer a clear separation between clinical recommendations and product offerings. The clinic does not currently offer full-body MRI or advanced imaging. Clinic-specific patient reviews are limited compared to the product side. For patients seeking Italy's deepest longevity assessment with rigorous scientific leadership, SoLongevity offers a compelling and evidence-oriented platform.